Company Overview - SOPHiA GENETICS is a cloud-native software company focused on data-driven medicine, utilizing AI to enhance patient care for cancer and rare disorders globally [3] - The company developed the SOPHiA DDM™ Platform, which analyzes complex multimodal data to provide real-time, actionable insights for hospitals, laboratories, and biopharma institutions [3] Financial Results Announcement - SOPHiA GENETICS will release its financial results for Q2 of fiscal year 2024 before U.S. markets open on August 6, 2024 [1] - A conference call to discuss the financial results and business outlook will take place at 8:00 a.m. EDT / 2:00 p.m. CET on the same day [1] Investor Relations - The conference call will be available via live webcast on the SOPHiA GENETICS Investor Relations Website, with a replay accessible after the event [2]
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024